pandem
coronaviru
diseas
emerg
major
health
crisi
sever
acut
respiratori
syndrom
coronaviru
infect
million
peopl
around
world
within
month
identif
human
pathogen
initi
infect
cell
sinc
decemb
acut
sever
viral
infectionivolv
primarili
respiratori
system
emerg
rapid
transmiss
around
world
million
peopl
within
month
name
coronaviru
diseas
world
health
organ
diseas
pandem
result
major
health
crisi
pathogen
attribut
sever
acut
respiratori
syndrom
coronaviru
novel
beta
coronaviru
close
relat
sever
acut
respiratori
syndrom
coronaviru
sarscov
result
mani
infect
death
throughout
world
unlik
seen
influenza
morbid
transmiss
modal
appear
sever
uncontrol
primari
pulmonari
injuri
subsequ
cardiovascular
complic
constitut
key
pathophysiolog
deadli
diseas
review
updat
summar
pathophysiolog
featur
possibl
underli
mechan
clinic
characterist
pulmonari
cardiovascular
injuri
highli
contagi
viru
identifi
primari
pathogen
respons
develop
belong
coronavirida
famili
structur
function
similar
member
betacoranaviru
subgroup
b
fig
thought
descend
bat
gene
pool
seventh
member
coronaviru
famili
known
infect
human
compris
positivesens
singlestrand
rna
size
among
coronavirus
capabl
caus
ill
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
reportedli
caus
sever
diseas
fatal
infect
coronavirus
remain
asymptomat
mildli
symptomat
normal
peopl
accord
fulllength
genom
sequenc
homolog
sarscov
like
sarscov
infect
lung
alveolar
epitheli
cell
receptormedi
endocytosi
associ
angiotensin
convert
enzym
ii
epidemiolog
studi
enrol
confirm
case
china
indic
overal
casefat
rate
wherea
sarscov
epidem
merscov
outbreak
mortal
itali
spain
franc
may
higher
closer
sarscov
may
due
strain
variat
yet
determin
howev
consider
rapidli
increas
number
confirm
case
evid
humantohuman
transmiss
infect
seem
stronger
sarscov
merscov
ultrastructur
examin
cryoelectron
microscopi
demonstr
bind
affin
appear
approxim
higher
sarscov
structur
explain
high
contagi
spite
fact
infect
million
individu
larg
unknown
viru
evolv
interact
microorgan
tabl
lung
vital
organ
heart
brain
shen
et
al
recent
report
genom
divers
patient
observ
metatranscriptom
sequenc
bronchoalveolar
lavag
fluid
sampl
communityacquir
pneumonia
healthi
individu
observ
limit
polymorph
divers
intrahost
set
substanti
proport
bacteria
sever
patient
similar
patient
noncoronavir
pneumonia
common
complic
viral
infect
especi
respiratori
virus
secondari
bacteri
infect
often
result
signific
increas
morbid
even
mortal
inde
retrospect
observ
studi
fatal
case
du
et
al
report
addit
infect
simultan
secondarili
pathogen
may
particip
develop
complic
contribut
sever
mortal
thu
coinfect
pathogen
certainli
complic
pathogenesi
manag
recommend
countri
includ
unit
state
adapt
similar
diagnost
procedur
harvest
certain
clinic
epidemiolog
inform
diagnosi
initi
test
sourc
respiratori
infect
implement
assess
epidemiolog
factor
assist
diagnosi
includ
inform
whether
person
close
contact
patient
laboratoryconfirm
within
day
symptom
onset
histori
travel
affect
geograph
area
epicent
within
day
clinic
profil
diagnosi
well
document
date
howev
new
evid
emerg
deadli
diseas
far
mysteri
previous
thought
mani
case
appear
atyp
easili
misdiagnost
tabl
wang
et
al
suggest
diagnos
confirm
case
base
suspect
case
one
item
pathogen
serolog
evid
follow
realtim
pcr
test
posit
viral
whole
genom
sequenc
show
high
homogen
known
novel
coronavirus
posit
specif
igm
antibodi
igg
antibodi
serum
test
chang
igg
antibodi
neg
posit
titer
rise
time
recoveri
phase
acut
phase
mainli
attack
respiratori
system
clinic
character
rapid
develop
pneumonia
sever
case
acut
respiratori
distress
syndrom
ard
multipl
organ
dysfunct
syndrom
death
rate
remain
high
admit
intens
care
ventil
due
complic
respiratori
cardiac
failur
epidemiolog
high
preval
cardiovascular
dysfunct
recent
report
patient
especi
critic
medic
condit
studi
patient
patient
diagnos
acut
myocardi
injuri
base
elev
highsensit
cardiac
troponin
hsctni
admit
intens
care
unit
icu
injuri
independ
associ
higher
risk
inhospit
mortal
henc
earli
myocardi
injuri
lead
poor
prognosi
patient
chang
cardiacspecif
biomark
peripher
blood
report
patient
state
hsctni
act
one
specif
biomark
myocardi
injuri
bind
sarscov
spike
protein
cardiomyocyt
surfac
also
trigger
pathway
activ
cc
motif
chemokin
ligand
profibrosi
factor
theori
support
autopsi
report
heart
sampl
sar
patient
presenc
sarscov
heart
associ
mark
downregul
express
well
signific
increas
macrophag
infiltr
interstiti
fibrosi
verifi
inhibit
involv
sarscovdriven
myocardi
injuri
specif
cellular
mechan
invad
damag
cardiomyocyt
clearli
demonstr
yet
probabl
share
similar
mechan
rel
sarscov
recent
studi
investig
ultrastructur
fulllength
human
cryoem
indic
also
invad
host
cell
via
spike
protein
trimer
bind
homodim
addit
interfac
receptor
bind
domain
spike
protein
quit
similar
sarscov
furthermor
serin
proteas
also
indispens
entri
given
high
similar
cellular
entri
sarscov
reason
specul
interfer
express
way
howev
need
verifi
cardiomyocyt
studi
myocardi
oxygen
suppli
determin
coronari
blood
flow
oxygen
carri
capac
myocardi
oxygen
demand
determin
systol
wall
tension
contractil
heart
rate
physiolog
mechan
may
involv
myocardi
injuri
wellknown
pulmonari
dysfunct
primari
insult
induc
hypoxemia
hypotens
case
shock
consequencet
insuffici
oxygen
suppli
may
occur
multipl
organ
includ
heart
concomitantli
myocardi
oxygen
demand
increas
virusinfect
state
high
metabol
rate
induc
augment
burden
myocardium
among
mani
cytokin
serv
core
cytokin
storm
given
amplifi
cytokin
storm
stimul
product
proinflammatori
cytokin
also
result
vascular
leakag
interstiti
edema
moreov
also
shown
weaken
papillari
muscl
contract
caus
myocardi
dysfunct
addit
also
regard
marker
cytokin
storm
caus
cell
apoptosi
regul
axi
howev
antiinflammatori
cytokin
also
increas
patient
level
also
relat
diseas
sever
demonstr
close
relat
proand
antiinflamm
cytokin
storm
clear
contributor
myocardi
injuri
demonstr
studi
reveal
increas
level
significantli
associ
high
hstni
level
cardiacselect
biomark
myocardi
infarct
injuri
studi
need
explor
cytokin
express
cardiomyocyt
promot
better
understand
inflamm
cardiac
tissu
overal
direct
infect
imbal
myocardi
oxygen
suppli
demand
abnorm
immun
respons
constitut
plausibl
explan
myocardi
injuri
associ
note
howev
specul
mostli
base
clinic
observ
therefor
indepth
research
requir
understand
pathophysiolog
myocardi
injuri
order
contribut
futur
develop
effect
treatment
gener
clinic
symptom
found
covid
suggest
myocardi
inflamm
occur
patient
cytokin
storm
consequ
inflammatori
respons
suggest
mechan
contribut
myocardi
injuri
low
eat
densiti
show
chest
ct
scan
appear
highrisk
factor
myocardi
injuri
howev
low
eat
densiti
optim
imag
paramet
myocardi
injuri
sinc
indirect
sign
inflamm
may
substant
influenc
subject
factor
clinic
practic
imag
modal
high
sensit
specif
echocardiographi
myocardi
magnet
reson
imag
preferenti
chosen
appropri
treatment
mostli
restrict
support
measur
date
specif
therapi
avail
treat
diseas
preexist
poorhealth
condit
increas
risk
cardiovascular
comorbid
poorer
hydroxychloroquin
chloroquin
tradit
antimalari
autoimmun
diseas
drug
shown
control
infect
vitro
underli
mechan
may
involv
increas
endosom
ph
requir
viruscel
interfer
glycosyl
structur
evid
invas
cell
via
led
hypothesi
aceiarb
treatment
potenti
induc
overexpress
subsequ
increas
suscept
host
cell
invas
risk
infect
worsen
sever
diseas
therapi
less
evidencebas
foundat
also
worth
mention
plasma
treatment
mean
transfus
convalesc
plasma
contain
antiviru
polyclon
antibodi
prove
effect
treat
sar
patient
patient
observ
studi
although
number
patient
treat
small
make
scientif
sens
dilat
hors
serum
could
crossneutr
vitro
studi
gener
discomfort
typic
fever
fatigu
headach
muscl
ach
diarrhea
etc
sign
symptom
lung
airway
abnorm
typic
cough
dyspnea
total
white
blood
cell
count
show
normal
decreas
reduc
lymphocyt
count
earli
onset
stage
increas
neutrophil
advanc
case
realtim
pcr
test
posit
viral
sequenc
show
high
homogen
serum
test
posit
specif
igm
igg
chest
radiographi
ct
scan
show
multipl
mottl
groundglass
opac
without
consolid
lung
peripheri
schemat
demonstr
viral
injuri
lung
heart
trigger
lungheart
syndrom
combin
respiratori
cardiovascular
advers
event
condit
